{"id":5426,"date":"2025-06-30T23:11:00","date_gmt":"2025-06-30T23:11:00","guid":{"rendered":"https:\/\/www.orthogate.org\/press\/uncategorized\/stem-cell-therapy-for-musculoskeletal-conditions\/"},"modified":"2025-07-01T03:24:31","modified_gmt":"2025-07-01T03:24:31","slug":"stem-cell-therapy-for-musculoskeletal-conditions","status":"publish","type":"post","link":"https:\/\/www.orthogate.org\/press\/deep-research\/sports-medicine-pushing-the-boundaries-of-performance-and-recovery\/stem-cell-therapy-for-musculoskeletal-conditions\/","title":{"rendered":"Stem cell therapy for musculoskeletal conditions"},"content":{"rendered":"

Stem Cell Therapy for Musculoskeletal Conditions: A Comprehensive Review<\/b> <\/span><\/span><\/h1>\n\n

<\/p>\n

Stem cell therapy has emerged as a promising therapeutic approach for a wide range of musculoskeletal conditions, offering the potential to revolutionize regenerative medicine<\/span>1<\/sup><\/span>. This review summarizes the current state of research in this field, discussing the different types of stem cells, their potential applications, and the challenges in translating preclinical findings to clinical practice.<\/span><\/p>\n

Types of Stem Cells Used in Musculoskeletal Research<\/b> <\/span><\/span><\/h2>\n\n

Stem cells are undifferentiated cells with the remarkable ability to self-renew and differentiate into various specialized cell types. This unique property makes them attractive candidates for regenerative medicine and tissue engineering applications. In musculoskeletal research, several types of stem cells have been investigated:<\/span><\/p>\n\n\n\n\n\n\n\n\n
Stem Cell Type<\/b> <\/span><\/th>\n Source<\/b> <\/span><\/th>\n Differentiation Potential<\/b> <\/span><\/th>\n Advantages<\/b> <\/span><\/th>\n Disadvantages<\/b> <\/span><\/th>\n<\/tr>\n<\/thead>\n
Embryonic Stem Cells (ESCs)<\/span><\/td>\nInner cell mass of blastocysts<\/span><\/td>\nCan differentiate into all cell types in the body (pluripotent)<\/span><\/td>\nHighest differentiation potential<\/span><\/td>\nEthical concerns, risk of teratoma formation<\/span><\/td>\n<\/tr>\n
Adult Stem Cells<\/span><\/td>\nVarious adult tissues (bone marrow, adipose tissue, umbilical cord blood, synovial tissue)<\/span><\/td>\nMore restricted differentiation potential than ESCs (multipotent)<\/span><\/td>\nLower risk of teratoma formation, can be obtained from the patient’s own cells<\/span><\/td>\nLimited expansion capacity, may be affected by age or disease<\/span><\/td>\n<\/tr>\n
Induced Pluripotent Stem Cells (iPSCs)<\/span><\/td>\nReprogrammed adult cells (e.g., skin cells)<\/span><\/td>\nSimilar to ESCs (pluripotent)<\/span><\/td>\nCan be derived from the patient’s own cells, reducing the risk of immune rejection<\/span><\/td>\nMay require extensive manipulation, potential for genomic instability<\/span><\/td>\n<\/tr>\n
Mesenchymal Stem Cells (MSCs)<\/span><\/td>\nBone marrow, adipose tissue, umbilical cord blood, synovial tissue, etc.<\/span><\/td>\nCan differentiate into musculoskeletal tissues (e.g., cartilage, bone, muscle, tendons, ligaments)<\/span><\/td>\nRelatively easy to isolate and expand, immunomodulatory properties<\/span><\/td>\nLimited proliferation capacity, may undergo hypertrophic differentiation<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Ethical considerations surrounding the use of different stem cell sources are crucial. While adult stem cells and iPSCs pose fewer ethical concerns, the use of ESCs raises questions about the destruction of embryos. Responsible use of stem cell technologies and adherence to ethical guidelines are essential<\/span>2<\/sup><\/span>.<\/span><\/p>\n

Potential Applications of Stem Cell Therapy for Musculoskeletal Conditions<\/b> <\/span><\/span><\/h2>\n\n

Stem cell therapy holds promise for treating various musculoskeletal conditions by not only alleviating symptoms but also addressing the underlying causes of these conditions<\/span>3<\/sup><\/span>. This includes:<\/span><\/p>\n

    \n
  1. Osteoarthritis:<\/b> <\/span> MSCs have shown potential in reducing pain, improving function, and potentially delaying the progression of osteoarthritis<\/span>4<\/sup><\/span>. They can be injected directly into the affected joint or used to engineer cartilage tissue in the laboratory<\/span>4<\/sup><\/span>. Some studies suggest that stem cell therapy may provide long-term pain relief for osteoarthritis<\/span>4<\/sup><\/span>.<\/span><\/li>\n
  2. Rheumatoid Arthritis:<\/b> <\/span> MSCs have immunomodulatory properties that can help regulate the immune response and reduce inflammation in rheumatoid arthritis<\/span>3<\/sup><\/span>. They may also promote tissue repair and improve joint function<\/span>3<\/sup><\/span>.<\/span><\/li>\n
  3. Osteoporosis:<\/b> <\/span> Stem cell therapy for osteoporosis aims to increase bone mineral density and reduce fracture risk<\/span>7<\/sup><\/span>. MSCs can differentiate into bone-forming cells and secrete factors that promote bone regeneration<\/span>7<\/sup><\/span>.<\/span><\/li>\n
  4. Muscle Injuries:<\/b> <\/span> Stem cell therapy can aid in the repair and regeneration of damaged muscle tissue, accelerating recovery and improving muscle function<\/span>9<\/sup><\/span>. This includes muscle strains, tears, and other acute or chronic muscle injuries<\/span>11<\/sup><\/span>.<\/span><\/li>\n
  5. Tendon and Ligament Injuries:<\/b> <\/span> Stem cells have the potential to differentiate into tendon and ligament cells, promoting healing and reducing the risk of re-injury<\/span>12<\/sup><\/span>.<\/span><\/li>\n
  6. Cartilage Damage:<\/b> <\/span> Stem cell therapy has shown promise in treating cartilage damage, such as meniscus tears, which are common in athletes<\/span>13<\/sup><\/span>.<\/span><\/li>\n
  7. Bone Injuries:<\/b> <\/span> Stem cell therapies are being explored for their potential to repair cranial bone loss, a significant clinical challenge<\/span>14<\/sup><\/span>.<\/span><\/li>\n
  8. Aging Frailty:<\/b> <\/span> Clinical trials are underway to investigate the potential of MSCs in addressing aging frailty<\/span>15<\/sup><\/span>.<\/span><\/li>\n
  9. Cardiovascular Disease Prevention:<\/b> <\/span> Research is exploring the use of MSCs in preventing cardiovascular disease<\/span>15<\/sup><\/span>.<\/span><\/li>\n
  10. Drug Discovery:<\/b> <\/span> Stem cells can guide drug discovery by providing opportunities for high-throughput screening and disease modeling<\/span>16<\/sup><\/span>.<\/span><\/li>\n
  11. Lumbar Spinal Stenosis:<\/b> <\/span> Stem cell therapy is being investigated as a potential treatment for lumbar spinal stenosis<\/span>7<\/sup><\/span>.<\/span><\/li>\n
  12. Degenerative Disc Disease (DDD):<\/b> <\/span> Stem cell therapy is being explored for its potential to treat degenerative disc disease<\/span>7<\/sup><\/span>.<\/span><\/li>\n
  13. Osteogenesis Imperfecta (OI):<\/b> <\/span> Stem cell therapy is being investigated as a potential treatment for osteogenesis imperfecta<\/span>7<\/sup><\/span>.<\/span><\/li>\n<\/ol>\n

    The use of biomaterials and scaffolds in stem cell therapy can enhance cell delivery and tissue regeneration. Biomaterials provide structural support and can be combined with stem cells to create tissue-engineered constructs for implantation<\/span>17<\/sup><\/span>. Growth factors, such as platelet-rich plasma (PRP), are often used in conjunction with stem cell therapy to further enhance the healing process. PRP contains growth factors that stimulate tissue repair and regeneration<\/span>18<\/sup><\/span>.<\/span><\/p>\n

    Meta-analyses of Stem Cell Therapy for Musculoskeletal Conditions<\/b> <\/span><\/span><\/h2>\n\n

    Meta-analyses have been conducted to evaluate the overall efficacy and safety of stem cell therapy for musculoskeletal conditions. A meta-analysis of studies on horses with tendon and ligament injuries found that mesenchymal stem cells (MSCs) and MSCs administered concurrently with PRP reduced the risk of re-injury<\/span>19<\/sup><\/span>. Another meta-analysis of randomized controlled trials on stem cell therapy for knee osteoarthritis found that stem cell therapy was superior to traditional treatments in reducing pain without significant side effects<\/span>20<\/sup><\/span>.<\/span><\/p>\n

    Challenges in Translating Preclinical Findings to Clinical Practice<\/b> <\/span><\/span><\/h2>\n\n

    Despite the promising preclinical findings, several challenges remain in translating stem cell therapy for musculoskeletal conditions into clinical practice:<\/span><\/p>\n

    Biological Challenges<\/b> <\/span><\/span><\/h3>\n\n
      \n
    1. Optimal Cell Source and Dosage:<\/b> <\/span> Identifying the most suitable stem cell source, dosage, and delivery method for each condition is crucial<\/span>12<\/sup><\/span>. Different sources of MSCs, such as bone marrow, adipose tissue, and synovial tissue, have varying properties and may be more suitable for specific applications<\/span>22<\/sup><\/span>.<\/span><\/li>\n
    2. Inflammatory Joint Environment:<\/b> <\/span> The inflammatory environment in conditions like osteoarthritis and rheumatoid arthritis can affect stem cell function and survival<\/span>16<\/sup><\/span>. It is important to consider the inflammatory joint environment when evaluating stem cell therapy for these conditions<\/span>16<\/sup><\/span>.<\/span><\/li>\n
    3. Phenotypic Instability:<\/b> <\/span> Maintaining the stability of the desired cell phenotype after transplantation is essential for long-term efficacy<\/span>16<\/sup><\/span>.<\/span><\/li>\n
    4. Microenvironment:<\/b> <\/span> The microenvironment surrounding stem cells, including factors like acidity, oxygen level, and nutrient supply, can influence their behavior and differentiation<\/span>17<\/sup><\/span>.<\/span><\/li>\n<\/ol>\n

      Manufacturing Challenges<\/b> <\/span><\/span><\/h3>\n\n
        \n
      1. Scaling Up Production:<\/b> <\/span> Manufacturing clinical-grade stem cell products in a cost-effective and consistent manner is a significant challenge<\/span>23<\/sup><\/span>.<\/span><\/li>\n<\/ol>\n

        Clinical Challenges<\/b> <\/span><\/span><\/h3>\n\n
          \n
        1. Long-Term Safety and Efficacy:<\/b> <\/span> More research is needed to establish the long-term safety and efficacy of stem cell therapy for musculoskeletal conditions<\/span>2<\/sup><\/span>.<\/span><\/li>\n
        2. Allogeneic vs. Autologous Stem Cell Products:<\/b> <\/span> The use of allogeneic (donor) versus autologous (patient’s own) stem cell products presents different advantages and disadvantages. Allogeneic products may be more readily available but carry a risk of immune rejection, while autologous products require a harvesting procedure from the patient<\/span>21<\/sup><\/span>.<\/span><\/li>\n
        3. Cost:<\/b> <\/span> Stem cell therapy can be expensive, and the cost can vary depending on factors like cell source and dosage<\/span>25<\/sup><\/span>.<\/span><\/li>\n
        4. Regulatory Challenges:<\/b> <\/span> The FDA plays a crucial role in regulating stem cell products, and rigorous clinical trials are needed to demonstrate safety and efficacy<\/span>2<\/sup><\/span>.<\/span><\/li>\n
        5. Potential Risks:<\/b> <\/span> Stem cell therapy carries potential risks, such as teratoma formation (with pluripotent stem cells) or immune rejection (with allogeneic cells)<\/span>2<\/sup><\/span>.<\/span><\/li>\n
        6. Patient Selection:<\/b> <\/span> There are currently no formal medical guidelines for patient selection for stem cell therapy. Careful consideration of individual factors, such as age, health status, and the specific condition being treated, is essential<\/span>26<\/sup><\/span>.<\/span><\/li>\n<\/ol>\n

          Understanding the underlying molecular mechanisms of musculoskeletal disorders is crucial for developing effective stem cell therapies<\/span>24<\/sup><\/span>.<\/span><\/p>\n

          Clinical Trials and Future Directions<\/b> <\/span><\/span><\/h2>\n\n

          Numerous clinical trials are underway to evaluate the safety and efficacy of stem cell therapy for various musculoskeletal conditions<\/span>27<\/sup><\/span>. These trials are crucial for determining the optimal cell types, dosages, and delivery methods for different conditions<\/span>21<\/sup><\/span>. Future research should focus on:<\/span><\/p>\n

            \n
          1. Understanding the Mechanisms of Action:<\/b> <\/span> A deeper understanding of how stem cells interact with the host tissue and promote regeneration is needed<\/span>24<\/sup><\/span>.<\/span><\/li>\n
          2. Developing Standardized Protocols:<\/b> <\/span> Standardized protocols for cell isolation, expansion, and transplantation are essential for ensuring consistent treatment outcomes<\/span>28<\/sup><\/span>.<\/span><\/li>\n
          3. Improving Cell Delivery and Retention:<\/b> <\/span> Strategies to enhance cell delivery and retention at the injury site are crucial for maximizing therapeutic efficacy<\/span>28<\/sup><\/span>.<\/span><\/li>\n
          4. Addressing the Challenges of the Inflammatory Environment:<\/b> <\/span> Developing strategies to overcome the negative effects of inflammation on stem cell function is important<\/span>16<\/sup><\/span>.<\/span><\/li>\n<\/ol>\n

            Ongoing Clinical Trials for Stem Cell Therapy in Musculoskeletal Conditions<\/b> <\/span><\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n
            Condition<\/b> <\/span><\/th>\n Cell Type<\/b> <\/span><\/th>\n Intervention<\/b> <\/span><\/th>\n Study Phase<\/b> <\/span><\/th>\n<\/tr>\n<\/thead>\n
            Osteoarthritis<\/span><\/td>\nAutologous bone marrow concentrate<\/span><\/td>\nInjection into the knee joint<\/span><\/td>\nPhase I\/II<\/span><\/td>\n<\/tr>\n
            Osteoarthritis<\/span><\/td>\nAllogeneic mesenchymal stromal cells<\/span><\/td>\nInjection into the knee joint<\/span><\/td>\nPhase II<\/span><\/td>\n<\/tr>\n
            Cartilage Defects<\/span><\/td>\nAutologous chondrocytes<\/span><\/td>\nImplantation with a collagen membrane<\/span><\/td>\nPhase III<\/span><\/td>\n<\/tr>\n
            Rotator Cuff Tears<\/span><\/td>\nBone marrow-derived MSCs<\/span><\/td>\nInjection into the rotator cuff<\/span><\/td>\nPhase I\/II<\/span><\/td>\n<\/tr>\n
            Degenerative Disc Disease<\/span><\/td>\nAdipose-derived stem cells<\/span><\/td>\nInjection into the intervertebral disc<\/span><\/td>\nPhase I<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

            This table provides a snapshot of some ongoing clinical trials. For a comprehensive list of active studies, please refer to ClinicalTrials.gov<\/span>29<\/sup><\/span>.<\/span><\/p>\n

            Conclusion<\/b> <\/span><\/span><\/h2>\n\n

            Stem cell therapy holds immense potential for revolutionizing the treatment of musculoskeletal conditions<\/span>1<\/sup><\/span>. While challenges remain in translating preclinical findings to clinical practice, ongoing research and clinical trials are paving the way for the development of safe and effective stem cell-based therapies.<\/span><\/p>\n

            Works cited<\/b><\/span><\/h4>\n\n

            1. Cell-based therapy in the treatment of musculoskeletal diseases – Oxford Academic, accessed February 17, 2025, https:\/\/academic.oup.com\/stcltm\/article\/13\/10\/959\/7748363<\/a><\/p>\n

            2. 3. Clinical Translation of Stem Cell-based Interventions, accessed February 17, 2025, https:\/\/www.isscr.org\/guidelines\/blog-post-title-one-ed2td-6fcdk-5zr5l<\/a><\/p>\n

            3. Stem Cell Therapy for Rheumatoid Arthritis – Swiss Medica, accessed February 17, 2025, https:\/\/www.startstemcells.com\/rheumatoid-arthritis-stem-cell-treatment.html<\/a><\/p>\n

            4. Stem Cell Treatment for Osteoarthritis – MyHealth Alberta, accessed February 17, 2025, https:\/\/myhealth.alberta.ca\/Alberta\/Pages\/stem-cell-treatment-for-osteoarthritis.aspx<\/a><\/p>\n

            5. Stem cell therapy: an alternative for osteoarthritis of the knee | Palmdale Regional Medical Center, accessed February 17, 2025, https:\/\/www.swhpalmdaleregional.com\/stem-cell-therapy-alternative-osteoarthritis-knee<\/a><\/p>\n

            6. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis – PMC, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8584240\/<\/a><\/p>\n

            7. Stem Cell Treatment for Osteoporosis & Bone Regeneration, accessed February 17, 2025, https:\/\/stemcellthailand.org\/therapies\/osteoporosis\/<\/a><\/p>\n

            8. Costa Rica Osteoporosis Stem Cell Treatment, Why it Works, accessed February 17, 2025, https:\/\/stemcellstransplantinstitute.com\/2017\/09\/26\/stem-cells-osteoporosis-treatment\/<\/a><\/p>\n

            9. Stem Cell Therapy for Athletes: Enhanced Recovery (2024), accessed February 17, 2025, https:\/\/www.dvcstem.com\/post\/can-stem-cells-help-athletes<\/a><\/p>\n

            10. Stem Cell Therapy for Muscle Tears | Stem Cell Clinic Bridgewater MA, accessed February 17, 2025, https:\/\/www.orthopedicstemcellsboston.com\/stem-cell-therapy-for-muscle-tears.html<\/a><\/p>\n

            11. Stem Cell Treatment for Muscles | Swiss Medica, accessed February 17, 2025, https:\/\/www.startstemcells.com\/stem-cell-treatment-for-muscle-cells.html<\/a><\/p>\n

            12. Stem cell technology for tendon regeneration: current status, challenges, and future research directions – PubMed Central, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4685888\/<\/a><\/p>\n

            13. Stem Cell Therapy – Dr Bassam Moses, accessed February 17, 2025, https:\/\/www.drmoses.com.au\/rest\/ice\/stem-cell-therapy<\/a><\/p>\n

            14. Mining Cell Therapy to Repair Injured Bones and Tendons – Cedars-Sinai, accessed February 17, 2025, https:\/\/www.cedars-sinai.org\/newsroom\/mining-cell-therapy-to-repair-injured-bones-and-tendons\/<\/a><\/p>\n

            15. Clinical Trials in the Bahamas Using Mesenchymal Stem Cells, accessed February 17, 2025, https:\/\/www.cellcolabsclinical.com\/<\/a><\/p>\n

            16. Stem cell-based therapies for osteoarthritis: Challenges and …, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3616879\/<\/a><\/p>\n

            17. Stem cell-based therapies for musculoskeletal regeneration – The Physiological Society, accessed February 17, 2025, https:\/\/www.physoc.org\/magazine-articles\/stem-cell-based-therapies-for-musculoskeletal-regeneration\/<\/a><\/p>\n

            18. Exploring Stem Cell Therapy in Sports Medicine: Benefits, Considerations, and Treatment Options, accessed February 17, 2025, https:\/\/www.eliteorthopaedic.com\/blog\/whats-the-deal-with-stem-cells\/<\/a><\/p>\n

            19. Stem cells and platelet-rich plasma for the treatment of naturally occurring equine tendon and ligament injuries: a systematic review and meta-analysis in – AVMA Journals, accessed February 17, 2025, https:\/\/avmajournals.avma.org\/view\/journals\/javma\/262\/S1\/javma.23.12.0723.xml<\/a><\/p>\n

            20. Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: A meta-analysis, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7220405\/<\/a><\/p>\n

            21. Hurdles to clinical translation of human induced pluripotent stem cells – PMC, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4563685\/<\/a><\/p>\n

            22. academic.oup.com, accessed February 17, 2025, https:\/\/academic.oup.com\/stcltm\/article\/13\/10\/959\/7748363#:~:text=Cell%20sourcing%20of%20MSCs&text=Bone%20marrow%2Dderived%20MSCs%20(BMD,periosteum%2C%20fat%2C%20and%20muscle.<\/a><\/p>\n

            23. Full article: The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges – Taylor & Francis Online, accessed February 17, 2025, https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/rme.14.73<\/a><\/p>\n

            24. Efficacy and Safety of Stem Cell Therapy for Orthopedic Conditions, Including Osteoarthritis and Bone Defects – PMC, accessed February 17, 2025, https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11299758\/<\/a><\/p>\n

            25. Stem Cell Therapy for Arthritis: Success Rate & Cost Info (2024), accessed February 17, 2025, https:\/\/www.dvcstem.com\/post\/stem-cell-therapy-for-arthritis<\/a><\/p>\n

            26. Stem Cell Therapy for Sports Injuries, accessed February 17, 2025, https:\/\/www.sports-health.com\/treatment\/regenerative-medicine\/stem-cell-therapy-sports-injuries<\/a><\/p>\n

            27. Musculoskeletal Regeneration – Center for Regenerative Biotherapeutics – Mayo Clinic Research, accessed February 17, 2025, https:\/\/www.mayo.edu\/research\/centers-programs\/center-regenerative-biotherapeutics\/focus-areas\/musculoskeletal-regeneration<\/a><\/p>\n

            28. Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder | Brain | Oxford Academic, accessed February 17, 2025, https:\/\/academic.oup.com\/brain\/article\/145\/5\/1584\/6545253<\/a><\/p>\n

            29. Clinical Trials Nationwide – KUMC, accessed February 17, 2025, https:\/\/www.kumc.edu\/research\/midwest-stem-cell-therapy-center\/research\/nationwide-clinical-trials.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

            Stem Cell Therapy for Musculoskeletal Conditions: A Comprehensive Review Stem cell therapy has emerged as a promising therapeutic approach for a wide range of musculoskeletal conditions, offering the potential to revolutionize regenerative medicine1. This review summarizes the current state of research in this field, discussing the different types of stem cells, their potential applications, and […]<\/p>\n","protected":false},"author":1,"featured_media":5425,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[528],"tags":[806,746,807,804,518,162,600,159,602,805],"class_list":["post-5426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sports-medicine-pushing-the-boundaries-of-performance-and-recovery","tag-bone-injuries","tag-cartilage-damage","tag-clinical-trials","tag-muscle-injuries","tag-musculoskeletal-conditions","tag-osteoarthritis","tag-regenerative-medicine","tag-rheumatoid-arthritis","tag-stem-cell-therapy","tag-tendon-injuries"],"_links":{"self":[{"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/posts\/5426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/comments?post=5426"}],"version-history":[{"count":0,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/posts\/5426\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/media\/5425"}],"wp:attachment":[{"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/media?parent=5426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/categories?post=5426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.orthogate.org\/press\/wp-json\/wp\/v2\/tags?post=5426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}